Favorable outcome of a patient with an unclassifiable myelodysplastic syndrome/myeloproliferative neoplasm treated with allogeneic hematopoietic stem cell transplantation

The entity myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome is characterized by the coexistence of both myeloproliferative and myelodysplastic features in the bone marrow. Risk assessment and treatment recommendations have not been standardized, and clinicians rely on updated pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemsing, Anette Lodvir, Gjertsen, Bjørn Tore, Spetalen, Signe, Helgeland, Lars, Reikvam, Håkon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841861/
https://www.ncbi.nlm.nih.gov/pubmed/33628448
http://dx.doi.org/10.1177/2050313X20988413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841861/
https://www.ncbi.nlm.nih.gov/pubmed/33628448
http://dx.doi.org/10.1177/2050313X20988413

Ejemplares similares